Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
FAR Biotech logo — Shining a light on drug discovery.

FAR Biotech

Shining a light on drug discovery.

6 employees

General Information

Company Name FAR Biotech
Employees 6
Social

Get notified when FAR Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About FAR Biotech

FAR Biotech is a preclinical, computational drug discovery company with a focus on hard-to-drug targets of high scientific and commercial value. Founded by Dr. Martin Martinov after 25 years in academia and industry, the company seeks to shine a light on drug discovery in areas with high unmet clinical needs. Their proprietary technology allows for the rapid identification of novel, structurally diverse, optimized lead molecules. Its key differentiator is a complete and rigorous quantum mechanical representation of drug-target interactions, augmented by AI/machine learning & big data. FAR's quantum biomodelling platform has been validated preclinically across neurodegeneration, oncology, and infectious diseases. Overall, FAR Biotech's commitment to leveraging advanced technologies and its success in drug discovery bode well for its future growth and potential contributions to addressing unmet clinical needs in the healthcare industry. As a venture capital firm, considering FAR Biotech for investment may prove to be a strategic opportunity due to its innovative approach, experienced founder, and validated platform in high-value therapeutic areas.

Taxonomy: Drug Discovery, Computational Drug Discovery, Preclinical Research, Quantum Biomodeling, In Silico Drug Discovery, Neurodegenerative Diseases, Oncology, Infectious Diseases, Quantum Mechanics, Pharmaceuticals, Lighthouse

No funding data available for FAR Biotech yet.

Get notified when FAR Biotech raises funding

FAR Biotech Alternatives & Competitors

FAR Biotech vs
Pharmacelera
Pharmacelera Spain

Mine enhanced chemical space. Design superior candidates

Seed
28 employees
Biotechnology, Information Technology
FAR Biotech vs
Kuano
Kuano United Kingdom

Providing innovative quantum and AI solutions for drug discovery and design.

Seed
19 employees
AI, Biotechnology
FAR Biotech vs
Pending AI
Pending AI

Designing Higher-⁠Quality Medicines with Next⁠-⁠Generation Computational Drug Discovery

FAQ About FAR Biotech

Shining a light on drug discovery.
FAR Biotech has approximately 6 employees.
Top alternatives and competitors to FAR Biotech include Pharmacelera, Kuano, Pending AI, High Q Technologies , Perpetual Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FAR Biotech and Pharmacelera are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors FAR Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes